vs
豪洛捷（HOLX）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
豪洛捷的季度营收约是Rackspace Technology, Inc.的1.5倍（$1.0B vs $682.8M），豪洛捷净利率更高（17.1% vs -4.8%，领先21.9%），豪洛捷同比增速更快（2.5% vs -0.4%），豪洛捷自由现金流更多（$215.2M vs $56.0M），过去两年豪洛捷的营收复合增速更高（1.5% vs -0.6%）
豪洛捷是一家总部位于美国的医疗科技企业，核心业务聚焦女性健康领域，旗下产品涵盖诊断、外科手术及医学影像类专业医疗设备，为全球各地的医疗场景提供优质技术与产品支持。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
HOLX vs RXT — 直观对比
营收规模更大
HOLX
是对方的1.5倍
$682.8M
营收增速更快
HOLX
高出3.0%
-0.4%
净利率更高
HOLX
高出21.9%
-4.8%
自由现金流更多
HOLX
多$159.2M
$56.0M
两年增速更快
HOLX
近两年复合增速
-0.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $682.8M |
| 净利润 | $179.1M | $-32.7M |
| 毛利率 | 56.0% | 17.6% |
| 营业利润率 | 22.6% | -0.5% |
| 净利率 | 17.1% | -4.8% |
| 营收同比 | 2.5% | -0.4% |
| 净利润同比 | -10.9% | 41.6% |
| 每股收益（稀释后） | $0.79 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HOLXRXT
| Q4 25 | $1.0B | $682.8M | ||
| Q3 25 | $1.0B | $671.2M | ||
| Q2 25 | $1.0B | $666.3M | ||
| Q1 25 | $1.0B | $665.4M | ||
| Q4 24 | $1.0B | $685.6M | ||
| Q3 24 | $988.0M | $675.8M | ||
| Q2 24 | $1.0B | $684.9M | ||
| Q1 24 | $1.0B | $690.8M |
净利润HOLXRXT
| Q4 25 | $179.1M | $-32.7M | ||
| Q3 25 | $187.2M | $-67.1M | ||
| Q2 25 | $194.9M | $-54.5M | ||
| Q1 25 | $-17.4M | $-71.5M | ||
| Q4 24 | $201.0M | $-56.0M | ||
| Q3 24 | $178.6M | $-186.6M | ||
| Q2 24 | $194.5M | $25.0M | ||
| Q1 24 | $169.9M | $-640.6M |
毛利率HOLXRXT
| Q4 25 | 56.0% | 17.6% | ||
| Q3 25 | 55.6% | 19.4% | ||
| Q2 25 | 56.3% | 19.4% | ||
| Q1 25 | 37.5% | 19.1% | ||
| Q4 24 | 56.8% | 19.2% | ||
| Q3 24 | 56.4% | 20.3% | ||
| Q2 24 | 55.4% | 19.2% | ||
| Q1 24 | 53.3% | 19.2% |
营业利润率HOLXRXT
| Q4 25 | 22.6% | -0.5% | ||
| Q3 25 | 22.6% | -5.1% | ||
| Q2 25 | 24.9% | -3.8% | ||
| Q1 25 | -0.7% | -5.8% | ||
| Q4 24 | 22.5% | -4.2% | ||
| Q3 24 | 23.3% | -25.7% | ||
| Q2 24 | 24.1% | -7.9% | ||
| Q1 24 | 20.7% | -94.5% |
净利率HOLXRXT
| Q4 25 | 17.1% | -4.8% | ||
| Q3 25 | 17.8% | -10.0% | ||
| Q2 25 | 19.0% | -8.2% | ||
| Q1 25 | -1.7% | -10.7% | ||
| Q4 24 | 19.7% | -8.2% | ||
| Q3 24 | 18.1% | -27.6% | ||
| Q2 24 | 19.2% | 3.7% | ||
| Q1 24 | 16.7% | -92.7% |
每股收益（稀释后）HOLXRXT
| Q4 25 | $0.79 | $-0.13 | ||
| Q3 25 | $0.84 | $-0.28 | ||
| Q2 25 | $0.86 | $-0.23 | ||
| Q1 25 | $-0.08 | $-0.31 | ||
| Q4 24 | $0.87 | $-0.20 | ||
| Q3 24 | $0.75 | $-0.82 | ||
| Q2 24 | $0.82 | $0.11 | ||
| Q1 24 | $0.72 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.4B | $105.8M |
| 总债务越低越好 | $2.5B | $2.7B |
| 股东权益账面价值 | $5.2B | $-1.2B |
| 总资产 | $9.2B | $2.8B |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资HOLXRXT
| Q4 25 | $2.4B | $105.8M | ||
| Q3 25 | $2.2B | $99.5M | ||
| Q2 25 | $1.9B | $103.9M | ||
| Q1 25 | $1.6B | $128.0M | ||
| Q4 24 | $2.0B | $144.0M | ||
| Q3 24 | $2.3B | $157.1M | ||
| Q2 24 | $2.4B | $190.2M | ||
| Q1 24 | $2.2B | $282.6M |
总债务HOLXRXT
| Q4 25 | $2.5B | $2.7B | ||
| Q3 25 | $2.5B | $2.8B | ||
| Q2 25 | $2.5B | $2.8B | ||
| Q1 25 | $2.5B | $2.8B | ||
| Q4 24 | $2.5B | $2.8B | ||
| Q3 24 | $2.5B | $2.8B | ||
| Q2 24 | $2.5B | $2.9B | ||
| Q1 24 | $2.6B | $3.0B |
股东权益HOLXRXT
| Q4 25 | $5.2B | $-1.2B | ||
| Q3 25 | $5.0B | $-1.2B | ||
| Q2 25 | $4.8B | $-1.1B | ||
| Q1 25 | $4.6B | $-1.1B | ||
| Q4 24 | $4.8B | $-1.0B | ||
| Q3 24 | $5.1B | $-949.7M | ||
| Q2 24 | $5.0B | $-756.2M | ||
| Q1 24 | $4.8B | $-787.2M |
总资产HOLXRXT
| Q4 25 | $9.2B | $2.8B | ||
| Q3 25 | $9.0B | $2.8B | ||
| Q2 25 | $8.8B | $2.9B | ||
| Q1 25 | $8.5B | $3.0B | ||
| Q4 24 | $8.7B | $3.1B | ||
| Q3 24 | $9.2B | $3.1B | ||
| Q2 24 | $8.9B | $3.4B | ||
| Q1 24 | $8.7B | $3.5B |
负债/权益比HOLXRXT
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | 0.53× | — | ||
| Q3 24 | 0.49× | — | ||
| Q2 24 | 0.51× | — | ||
| Q1 24 | 0.53× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.9M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $215.2M | $56.0M |
| 自由现金流率自由现金流/营收 | 20.5% | 8.2% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.28× | — |
| 过去12个月自由现金流最近4个季度 | $1.0B | $90.6M |
8季度趋势，按日历期对齐
经营现金流HOLXRXT
| Q4 25 | $229.9M | $59.7M | ||
| Q3 25 | $355.1M | $70.7M | ||
| Q2 25 | $343.3M | $8.4M | ||
| Q1 25 | $169.4M | $12.6M | ||
| Q4 24 | $189.3M | $54.3M | ||
| Q3 24 | $367.0M | $51.8M | ||
| Q2 24 | $405.8M | $24.1M | ||
| Q1 24 | $292.4M | $-90.3M |
自由现金流HOLXRXT
| Q4 25 | $215.2M | $56.0M | ||
| Q3 25 | $341.4M | $42.7M | ||
| Q2 25 | $330.5M | $-12.4M | ||
| Q1 25 | $153.9M | $4.3M | ||
| Q4 24 | $172.5M | $34.4M | ||
| Q3 24 | $350.6M | $27.3M | ||
| Q2 24 | $385.3M | $-14.5M | ||
| Q1 24 | $279.6M | $-118.4M |
自由现金流率HOLXRXT
| Q4 25 | 20.5% | 8.2% | ||
| Q3 25 | 32.5% | 6.4% | ||
| Q2 25 | 32.3% | -1.9% | ||
| Q1 25 | 15.3% | 0.6% | ||
| Q4 24 | 16.9% | 5.0% | ||
| Q3 24 | 35.5% | 4.0% | ||
| Q2 24 | 38.1% | -2.1% | ||
| Q1 24 | 27.5% | -17.1% |
资本支出强度HOLXRXT
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 1.3% | 4.2% | ||
| Q2 25 | 1.3% | 3.1% | ||
| Q1 25 | 1.5% | 1.2% | ||
| Q4 24 | 1.6% | 2.9% | ||
| Q3 24 | 1.7% | 3.6% | ||
| Q2 24 | 2.0% | 5.6% | ||
| Q1 24 | 1.3% | 4.1% |
现金转化率HOLXRXT
| Q4 25 | 1.28× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | 2.09× | 0.96× | ||
| Q1 24 | 1.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HOLX
| Molecular Diagnostics | $255.3M | 24% |
| Breast Imaging | $219.9M | 21% |
| Services | $216.4M | 21% |
| Capital Equipment Componentsand Software | $187.2M | 18% |
| Cytology Perinatal | $76.0M | 7% |
| Interventional Breast Solutions | $71.2M | 7% |
| Blood Screening | $8.4M | 1% |
| Other Typeof Revenue | $5.4M | 1% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
